Neuway Pharma GmbH:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Neuway Pharma GmbH - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10943
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:16
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ドイツ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Neuway Pharma GmbH (Neuway) is a provider of preclinical and clinical development for the treatment of central nervous system diseases. The company provides proprietary CNS drug delivery platform facilitates the transport of active drug substances through the blood-brain barrier. Its technology is based on a protein capsule which allows filling of its lumen with therapeutic active compounds. Neuway utilizes proprietary delivery technology, engineered protein capsules to develop therapeutics for orphan CNS diseases. The company offers EPCs which are deployed in a large variety of therapeutic active substances. It concentrates on orphan brain diseases such as Alzheimer’s disease, Parkinson’s disease and multiple sclerosis. Neuway is headquartered in Bonn, Germany.

Neuway Pharma GmbH – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Neuway Pharma GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Neuway Pharma GmbH, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Neuway Pharma GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Neuway Pharma GmbH, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Neuway Pharma GmbH, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Neuway Pharma GmbH, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Neuway Pharma Raises Additional USD3.5 Million in Series A Financing 10
Neuway Pharma Raises USD4 Million in Series A Financing 11
Licensing Agreements 12
Neuway Pharma Enters into Licensing Agreement with University of Zurich 12
Neuway Pharma GmbH – Key Competitors 13
Neuway Pharma GmbH – Key Employees 14
Neuway Pharma GmbH – Locations And Subsidiaries 15
Head Office 15
Appendix 16
Methodology 16
About GlobalData 16
Contact Us 16
Disclaimer 16

List of Tables
Neuway Pharma GmbH, Pharmaceuticals & Healthcare, Key Facts 2
Neuway Pharma GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Neuway Pharma GmbH, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Neuway Pharma GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Neuway Pharma GmbH, Deals By Therapy Area, 2012 to YTD 2018 8
Neuway Pharma GmbH, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Neuway Pharma Raises Additional USD3.5 Million in Series A Financing 10
Neuway Pharma Raises USD4 Million in Series A Financing 11
Neuway Pharma Enters into Licensing Agreement with University of Zurich 12
Neuway Pharma GmbH, Key Competitors 13
Neuway Pharma GmbH, Key Employees 14

List of Figures
Neuway Pharma GmbH, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Neuway Pharma GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Neuway Pharma GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Neuway Pharma GmbH, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Neuway Pharma GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Neuway Pharma GmbH, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Neuway Pharma GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Neuway Pharma GmbH, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Neuway Pharma GmbH:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Marquard & Bahls AG:企業の戦略的SWOT分析
    Marquard & Bahls AG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • Flex Foods Ltd:企業の戦略・SWOT・財務分析
    Flex Foods Ltd - Strategy, SWOT and Corporate Finance Report Summary Flex Foods Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • WidePoint Corp (WYY):企業の財務・戦略的SWOT分析
    Summary WidePoint Corp (WidePoint) operates as a technology company that provides telecommunications lifecycle management, managed mobility, and cybersecurity solutions. The company offers solutions such as telecom expense management, identity management solutions, mobile security solutions, cyberse …
  • DaVita Inc (DVA):企業の財務・戦略的SWOT分析
    DaVita Inc (DVA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Southwest Airlines Co:戦略・SWOT・企業財務分析
    Southwest Airlines Co - Strategy, SWOT and Corporate Finance Report Summary Southwest Airlines Co - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Formula Pharmaceuticals Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Formula Pharmaceuticals Inc (Formula Pharmaceuticals) is a biopharmaceutical company that develops chimeric antigen receptor immunotherapy for oncology and autoimmune diseases. The company provides its pipeline products such as CIK-CAR.CD19, used as B-lymphocyte surface antigen; CIK-CAR.CD33 …
  • Cosmo Pharmaceuticals NV (COPN):製薬・医療:M&Aディール及び事業提携情報
    Summary Cosmo Pharmaceuticals NV (Cosmo) is a pharmaceutical company that develops drugs for the treatment of gastro-intestinal diseases. The company develops its pharmaceutical products based on its multi matrix technology. Its proprietary clinical development pipeline intended for the treatment of …
  • Fomento de Construcciones y Contratas SA (FCC):電力:M&Aディール及び事業提携情報
    Summary Fomento de Construcciones y Contratas SA (FCC) is a citizen services company. It provides services in environmental, water, and infrastructure development sectors. The company manages and treats domestic and industrial waste; provides integrated water management services; and designs, develo …
  • Limacorporate SpA-医療機器分野:企業M&A・提携分析
    Summary Limacorporate SpA (Lima) is a medical device company that offers reconstructive and fixation orthopaedic solutions. The company offers large joint primary, large joint revision, extremities and fixation and promade products. It offers medical products for knee, hip, shoulder, cups, small joi …
  • PSR Group BV-製薬・医療分野:企業M&A・提携分析
    Summary PSR Group BV (PSR) is a contract research organization and staffing consultancy that operates through two divisions, namely, PSR Orphan Experts and PSR Pharma Resource. The company’s PSR Orphan Experts is a contract research organization that concentrates on orphan drug development. It provi …
  • Huons Global Co Ltd (084110):企業の財務・戦略的SWOT分析
    Huons Global Co Ltd (084110) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Granules India Ltd (GRANULES):企業の財務・戦略的SWOT分析
    Granules India Ltd (GRANULES) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Oil Search Ltd Oil & Gas Exploration and Production Operations and Cost Analysis – Q4, 2017
    Oil Search Ltd Oil & Gas Exploration and Production Operations and Cost Analysis - Q4, 2017 Summary Oil Search Ltd (Oil Search) is an independent upstream energy company. It explores for, develops and produces oil, natural gas and natural gas liquids (NGL). The company has majority of its oil and ga …
  • Steatite Limited:企業の戦略・SWOT・財務情報
    Steatite Limited - Strategy, SWOT and Corporate Finance Report Summary Steatite Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Calpine Corporation (CPN):電力:M&Aディール及び事業提携情報
    Summary Calpine Corporation (Calpine) is an electric and natural gas utility. The company produces electricity and thermal energy from natural gas, geothermal, and solar sources. It uses natural gas-fired combustion and renewable geothermal conventional steam turbine technologies to generate energy. …
  • Recylex SA:企業の戦略・SWOT・財務情報
    Recylex SA - Strategy, SWOT and Corporate Finance Report Summary Recylex SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Newalta Corp (NAL):石油・ガス:M&Aディール及び事業提携情報
    Summary Newalta Corp (Newalta) is a provider of sustainability-enhancing solutions to the oil and gas industry. It adopts technologies to maximize the value inherent in oil and gas exploration and production waste streams. The company provides engineered environmental solutions for waste management …
  • Brewers Fayre:企業の戦略・SWOT・財務分析
    Brewers Fayre - Strategy, SWOT and Corporate Finance Report Summary Brewers Fayre - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Competitive Power Ventures Inc:企業の戦略的SWOT分析
    Competitive Power Ventures Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major prod …
  • Vesuvius Plc:企業の戦略・SWOT・財務情報
    Vesuvius Plc - Strategy, SWOT and Corporate Finance Report Summary Vesuvius Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆